|
3 Humongous Health-Care Stocks This Week
Motley Fool That's four times higher than the stock's current level — even after the nice gains this week. Wedbush analyst Liana Moussatos thinks Omeros' eye surgery drug OMS302 could gain significantly higher market penetration than earlier thought if the drug … |